Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Addressing Disparities in Liver Cancer Care
Via Brandpoint
Topics Death Product Recall
Exposures Death Legal Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Collaborates to Support Potential Accelerated Pathway for ALS Treatment Candidate
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
The 10 Best Cities for Co-Warehousing in 2025
Via Syndication Cloud
Topics Product Recall
Exposures Legal Product Safety
Empowered by lived experience: How Lindsay and Matt found their voices in the narcolepsy community
Via Brandpoint
Topics Product Recall
Exposures Legal Product Safety
Plus Therapeutics Continues Rally On Friday - Here's Why
Via Benzinga
Exposures Product Safety
Tickers PSTV
FDA Nominee Marty Makary Faces The Senate. Will He Toe The RFK Jr. Line?
Via Investor's Business Daily
Exposures Product Safety
Tickers MCD MRNA
FDA Approves ARS Pharmaceuticals' Lower Dose Neffy Nasal Spray For Emergency Allergy Treatment
Via Benzinga
Exposures Product Safety
Tickers SPRY
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Advances ADI-100 Autoimmune Therapy Toward Clinical Trials
Via Investor Brand Network
Exposures Product Safety
Tickers ADTX APLIF TSX:APLI
Roots Farm Fresh Expands Allergen-Free Product Line Amid Rising Consumer Demand
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Tickers KR
FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine
Via Benzinga
Exposures Product Safety
Tickers BNTX
Why Is Hims & Hers Health Stock Trading Lower On Wednesday?
Via Benzinga
Exposures Product Safety
Tickers HIMS NVO
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at 2025 Virtual Investor Summit
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
Via NewMediaWire
Exposures COVID-19 Product Safety
Tickers SIGY
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
Via TheNewswire.com
Exposures COVID-19 Product Safety
Tickers SIGY
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
Via Newsfile
Exposures Product Safety
Tickers PHIO
Capricor Therapeutics’ Retail Chatter Explodes On Stocktwits After FDA Grants Priority Review For DMD Therapy
Via Stocktwits
Exposures Product Safety
Tickers CAPR IWM VTI XBI
Capricor Therapeutics Cell Therapy Goes Under Priority FDA Review For Duchenne Associated-Heart Condition
Via Benzinga
Exposures Product Safety
Tickers CAPR
China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer
Via Benzinga
Exposures Product Safety
Tickers ONC
Lineus Medical Completes $4.6 Million Series C Funding Round
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Highlights NV-387 as Potential Measles Treatment Amid Outbreak
Via Investor Brand Network
Topics Intellectual Property
Exposures COVID-19 Intellectual Property Product Safety
Tickers NNVC
Tirzepatide Weight Loss Injections Savings Program: Eligibility Check Announced
Via Press Release Distribution Service
Exposures Product Safety
Luxenberg Garbett Kelly & George P.C. Addresses Memory Loss After an Accident in Pennsylvania
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Nourish House Calls: New Research Challenges Misconceptions About Hormone Therapy in Menopause Treatment
Via Press Advantage
Exposures Product Safety
GSK's Twice-Yearly Depemokimab Reduces Nasal Polyp Size, Goes Under FDA Review
Via Benzinga
Exposures Product Safety
Tickers GSK
DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
Via Newsfile
Exposures Product Safety
Tickers CSE:DMED CSE:RVV DGNMF RVVTF
PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
Via Newsfile
Exposures Product Safety
Tickers CSE:PHRM PHRRF
NADIOL Responds to NMN Supplement Industry Shake-Up: Committed to Quality, Transparency & Your Health
Via Press Release Distribution Service
Exposures Product Safety
Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
Via Newsfile
Exposures Product Safety
Tickers ELTP
BioMedNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) and OS Therapies (NYSE American: OSTX) to Appear on RedChip’s Bloomberg TV Show
Via Investor Brand Network
Exposures Product Safety
Tickers CLDI OSTX
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.